Hikma Pharmaceuticals (HIK) Dividend Yield, Date & History GBX 1,953 +18.00 (+0.93%) (As of 12/20/2024 12:01 PM ET) Add Compare Share Share Dividend Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability Hikma Pharmaceuticals Dividend SummaryDividend Yield3.17%Annual DividendGBX 62Recent Dividend Payment Sep. 20 Dividend Payout Ratio 9,538.46% Hikma Pharmaceuticals (HIK) pays an annual dividend of GBX 62 per share, with a dividend yield of 3.17%. The next payment of GBX 0.32 per share was paid on Friday, September 20, to investors who owned the stock before the ex-dividend date of Thursday, August 15. The company currently pays out 9,538.46% of its earnings and 26.47% of its cash flow as dividends. Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Enter your email to sign up for newsletter Sign Up Skip Charts & View Dividend HistoryHIK Dividend Payments by QuarterDividend Payments by Quarter Chart DescriptionThe chart below displays up to four years of Hikma Pharmaceuticals' dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.Open Hikma Pharmaceuticals in Dividend Calculator HIK Dividend Yield Over TimeDividend Yield Over Time Chart DescriptionThe chart below tracks Hikma Pharmaceuticals' dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.Open Hikma Pharmaceuticals in Dividend Yield Calculator Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Hikma Pharmaceuticals vs. The CompetitionCompare Hikma Pharmaceuticals' annual dividend, yield, and 3-year growth rate with averages for Medical and LON companies to evaluate its performance against the market.TypeHikma PharmaceuticalsMedical CompaniesLON CompaniesAnnual DividendGBX 62GBX 0.06GBX 26.52Dividend Yield3.17%5.09%5.45%Hikma Pharmaceuticals Dividend Payout RatioDividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.TypePayout RatioBased on Trailing 12 Months of Earnings9,538.46%Based on This Year's Estimate40.65%Based on Cashflow26.47% Hikma Pharmaceuticals Dividend History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years All Time Time Frame * Start Date * End Date AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date8/8/2024$0.32-$0.1531.91%1.37%8/15/20248/15/20249/20/20242/22/2024$0.47+$0.2288.00%1.86%3/21/20243/21/20245/3/20248/3/2023$0.25-$0.1232.43%0.95%8/10/20238/10/20239/15/2023 Get the Latest News and Ratings for HIK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/23/2023$0.37+$0.1894.74%1.74%3/23/20233/23/20235/5/2023This table shows Hikma Pharmaceuticals' dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time. Hikma Pharmaceuticals Dividend - Frequently Asked Questions What is Hikma Pharmaceuticals's dividend yield? The current dividend yield for Hikma Pharmaceuticals is 3.17%. Learn more on HIK's dividend yield history. How much is Hikma Pharmaceuticals's annual dividend? The annual dividend for HIK shares is GBX 62. Learn more on HIK's annual dividend history. When was Hikma Pharmaceuticals's most recent dividend payment? Hikma Pharmaceuticals's most recent dividend payment of GBX 0.32 per share was made to shareholders on Friday, September 20, 2024. When was Hikma Pharmaceuticals's most recent ex-dividend date? Hikma Pharmaceuticals's most recent ex-dividend date was Thursday, August 15, 2024. When did Hikma Pharmaceuticals last increase or decrease its dividend? The most recent change in the company's dividend was a decrease of GBX 0.15 on Thursday, August 8, 2024. What is Hikma Pharmaceuticals's dividend payout ratio? The dividend payout ratio for HIK is: 9,538.46% based on the trailing year of earnings 40.65% based on this year's estimates 26.47% based on cash flow Is Hikma Pharmaceuticals a good dividend stock? Hikma Pharmaceuticals' dividend yield of 3.25% is lower than the average Medical company that issues a dividend. Hikma Pharmaceuticals' dividend payout ratio of 9,538.46% may not be sustainable. Looking at the stock as a whole, market analysts rate Hikma Pharmaceuticals stock as a Moderate Buy, forecasting growth opportunities and potential value appreciation. More Dividend Resources from MarketBeat Related Companies Alliance Pharma Dividend Yield Animalcare Group Dividend Yield Haleon Dividend Yield Smith & Nephew Dividend Yield ConvaTec Group Dividend Yield Dechra Pharmaceuticals Dividend Yield Genus Dividend Yield Spire Healthcare Group Dividend Yield Craneware Dividend Yield Uniphar Dividend Yield Dividend Tools Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Stock Lists Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Latest Articles ABM Industries Stock: A Dividend King at a DiscountMedtronic: A Dividend Aristocrat Powering Up for 2025 and Beyond3 Best Dividend Stocks to Buy as Interest Rates FallIntuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy3 High-Yield Dividend Stocks for Income Now and Growth LaterDividend King ABM Industries is on Track for New HighsWhy Altria Stock is Still a Good Dividend PlayGet Paid While You Wait - OneMain's Juicy DividendsAlphabet Changes the Narrative with Its First-Ever Dividend More Dividend News Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. This page (LON:HIK) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
